48
Growth Score in past quarter
pts
Heat Score 48 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1289025
MyCartis is develops and commercializes biomarkers for healthcare personalization needs.
Hilde Windels: CEOPast Role: Biocartis, CFO
About the Company
MyCartis is a privately held immunodiagnostics company, providing next generation solutions to detect and quantify protein biomarker signatures by providing precise and personalized novel clinical information for the benefit of researchers, clinicians and CRO’s.
MyCartis’ Evalution® platform with Dynamic Multi-Analyte Technology (DMAT®) inside,
provides a unique multiplex biomarker platform in combination with the required sensitivity and dynamic range for the integrated analysis of protein biomarkers. DMAT® utilizes proprietary disk-shaped micro-particles which carry a unique code and can be functionalized with specific proteins, antibodies, nucleic acids or other molecules. Thanks to th